Kirkland & Ellis has advised on the Triton Partners on completing the sale of a portfolio of four companies. The newly-formed vehicle,Triton IV Continuation Fund closed at...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Recipharm in the transaction. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisitions...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Recipharm on the deal. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisition of...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Apollo Therapeutics, while Kirkland & Ellis advised Patient Square Capital on the deal. Led by Patient Square Capital, and with participation from additional...
You must be a Standard 1 Year member to access this content.
